Acute myeloid leukemia (AML) is a heterogeneous disease for which usual treatment is very aggressive and produces severe side effects to the patients. In the search for a new and more effective drug, researchers from the ...
Jul 09, 2020
0
0
A new study by researchers at the RIKEN Center for Integrative Medical Science in Japan reports differences in blood cell mutations between Japanese and European populations. The study found that these pre-clinical mutations ...
Jun 24, 2020
1
121
In Texas, Hispanic patients with certain blood cancers had lower overall survival than non-Hispanic white patients, and Hispanic patients living at the United States/Mexico border had lower overall survival than those who ...
Jun 24, 2020
0
0
UConn associate professor of pharmaceutics Xiuling Lu, along with professor of chemistry Rajeswari M. Kasi, was part of a team that recently published a paper in Nature Cell Biology finding a commonly used chemotherapy drug ...
Jun 18, 2020
0
259
Acute myeloid leukemia (AML) is a hematological malignancy the incidence of which increases with age, that is biologically, phenotypically, and genetically very heterogeneous. Its treatment combines chemotherapy followed ...
Jun 17, 2020
0
8
A new study will enable clinicians to identify patients with aggressive leukemia who will not respond to chemotherapy and those who are most likely to benefit from a new immunotherapy.
Jun 05, 2020
0
113
New tailored therapies offer exciting prospects for treating acute myeloid leukemia (AML), but taking advantage of them may require waiting a week or more for genetic testing before starting treatment, posing a dilemma for ...
Jun 04, 2020
0
0
Acute myeloid leukemia (AML) is one of the most common forms of blood cancer among adults and is associated with a low survival rate, and leads to the inhibition of normal blood formation. Now, a research team at Lund University ...
Jun 03, 2020
0
1
Researchers at Mount Sinai have discovered that human acute myeloid leukemia (AML) stem cells are dependent on a transcription factor known as RUNX1, potentially providing a new therapeutic target to achieve lasting remissions ...
Jun 02, 2020
0
706
Scientific studies suggest that children with birth defects are at increased risk of cancer. However, it has not been assessed whether the type of cancer, the age at which they are diagnosed or the extent of cancer spread ...
May 29, 2020
0
0
Leukemia (American English) or leukaemia (British English) (from the Greek leukos λεύκος - white, and haima αίμα - blood) is a type of cancer of the blood or bone marrow characterized by an abnormal increase of immature white blood cells called "blasts". Leukemia is a broad term covering a spectrum of diseases. In turn, it is part of the even broader group of diseases affecting the blood, bone marrow, heart, and lymphoid system, which are all known as hematological neoplasms. Leukemia can also cause multiple organ failure.
In 2000, approximately 256,000 children and adults around the world developed some form of leukemia, and 209,000 died from it.[citation needed]
This text uses material from Wikipedia licensed under CC BY-SA
